Alembic Pharmaceuticals gets USFDA final approval for ANDA Docetaxel Injection

Alembic Pharmaceuticals Limited today announced that it has received final approval from the US Food & Drug Administration for its Abbreviated New Drug Application Docetaxel Injection.

Related Keywords

,Alembic Pharmaceuticals Limited ,Hospira Inc ,Alembic Pharmaceuticals ,Us Food Drug Administration ,Pharmaceuticals Limited ,Drug Administration ,Abbreviated New Drug Application ,Docetaxel Injection ,Singledose Vial ,Docetaxcel Injections ,Single Dose Vial ,Multiple Dose Vials ,Alembicpharmaceuticals ,Ine901l01018 ,Usfda ,Finalapproval ,Panda ,Docetaxelinjection ,